BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:43 PM
 | 
Apr 25, 2008
 |  BC Extra  |  Top Story

Isis off on mipomersen delay

Isis (NASDAQ:ISIS) fell $4.81 (29%) to $11.99 on Friday after it and partner Genzyme (NASDAQ:GENZ) announced delayed regulatory timelines for mipomersen. The partners said that an NDA seeking accelerated approval of the second-generation antisense inhibitor of Apo B-100 to treat homozygous familial hypercholesterolemia (hoFH) would be delayed until 2010...

Read the full 231 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >